Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IDEAYA Biosciences (IDYA) Operating Expenses: 2019-2024

Historic Operating Expenses for IDEAYA Biosciences (IDYA) over the last 6 years, with Dec 2024 value amounting to $334.0 million.

  • IDEAYA Biosciences' Operating Expenses rose 48.57% to $99.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $382.3 million, marking a year-over-year increase of 67.20%. This contributed to the annual value of $334.0 million for FY2024, which is 111.63% up from last year.
  • Per IDEAYA Biosciences' latest filing, its Operating Expenses stood at $334.0 million for FY2024, which was up 111.63% from $157.8 million recorded in FY2023.
  • IDEAYA Biosciences' 5-year Operating Expenses high stood at $334.0 million for FY2024, and its period low was $54.9 million during FY2020.
  • In the last 3 years, IDEAYA Biosciences' Operating Expenses had a median value of $157.8 million in 2023 and averaged $201.7 million.
  • Data for IDEAYA Biosciences' Operating Expenses shows a peak YoY spiked of 111.63% (in 2024) over the last 5 years.
  • Yearly analysis of 5 years shows IDEAYA Biosciences' Operating Expenses stood at $54.9 million in 2020, then spiked by 42.50% to $78.2 million in 2021, then skyrocketed by 45.04% to $113.4 million in 2022, then soared by 39.13% to $157.8 million in 2023, then surged by 111.63% to $334.0 million in 2024.